REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/06/2026
Voltar para busca
Dado oficial do USPTO
PANBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
09/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
08/04/2020
Data de registro
08/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/06/2021
Última transação
09/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
79
Localização do titular
IE
Examinador
GUROK, GALINA
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Abbott Rapid Diagnostics International Subsidiary Unlimited Company
Representantes
Michele H. Bowman Abbott Laboratories
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Control preparations for in vitro diagnostic testingscreeningconfirmation and analysisdiagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagentssolutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic testschemical reagents and assays for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections for laboratory or research useother than for medical or veterinary use; in vitro immunochromatographic testschemical reagents and assays for testing for respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections for laboratory or research useother than for medical or veterinary use
Classe 5
Diagnostic kits comprising medical diagnostic bioreagents for testing bloodbodily fluidnasal samplesoral samples and tissue for use in the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; medical diagnostic test strips for testing bloodhuman serumplasmabodily fluidnasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue for use in the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical usediagnostic preparations; diagnostic tests for medical usemedical diagnostic test media in the form of stripscassettescartridgescards for the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; medical diagnostic assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; in vitro medical diagnostic testsmedical diagnostic test media in the form of stripscassettescartridgescards for the detectionidentificationconfirmationmonitoring of respiratorycommunity acquiredhospital acquiredsexual healthgastro-entericvector borneblood borne pathogentropical disease infections; in vitro medical diagnostic assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; in vitro medical diagnostic test strips for use in the field of infectious disease; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical usemedical diagnostic reagents and assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue; medical diagnostics tests for the detectiondiagnosisscreeningconfirmation of infectionsmedical diagnostic reagents and assays for testing of body fluidsbloodhuman serumplasmanasal swab specimensnasopharyngeal swab specimensoral specimensoropharyngeal swab specimenstissue
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/01/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/11/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
28/09/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
28/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/03/2021
PUBO
PUBLISHED FOR OPPOSITION
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2021
RFNT
REFUSAL PROCESSED BY IB
25/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/08/2020
RFRR
REFUSAL PROCESSED BY MPU
06/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/07/2020
CNRT
NON-FINAL ACTION WRITTEN
30/06/2020
DOCK
ASSIGNED TO EXAMINER
25/06/2020
MAFR
APPLICATION FILING RECEIPT MAILED
19/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/05/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PANBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.